CAR-T cell therapy is a type of immunotherapy, which means it trains the immune system to find and attack cancer cells. To do this, a sample of blood is taken from the patient, and T-cells (white blood cells that are a part of the immune system) are separated out from the sample. Using genetic engineering in a laboratory, these T-cells are then modified to produce CARs (chimeric antigen receptors) on their surface. Once the CAR T-cells are infused back into the patient’s bloodstream, the new receptors allow them to recognize malignant cells, attach to them and kill them.
global patient services
Global Patient Services at Sheba
CONTACT SHEBA MEDICAL CENTER
The information on this website is for general knowledge purposes only and does not constitute medical advice, diagnosis, or treatment in any form. It is not a substitute for professional medical advice from a qualified physician.
Additionally, you are browsing the official – and only – website of Sheba Medical Center and not an agent or affiliate website.